Support for your Patients
Discover the selection of support materials for patients from different therapeutic areas
Our Products
▼ This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.
MAT-GB-2105264 (v3.0)
Date of preparation: July 2022